Physician profile
Rina Bhalani
NPI 1164951943
$1,783.93
in general payments reported to CMS, 2019-2025
17 companies · $40.60 in 2025
The $40.60 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $112 · 2022: $483 · 2023: $696 · 2024: $453 · 2025: $40.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,189.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $457.15 | 2021-2025 | Qulipta, Ubrelvy |
| Novo Nordisk INC | $373.93 | 2022-2024 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $186.31 | 2023-2024 | Jardiance, Mounjaro |
| Procept Biorobotics Corporation | $125.77 | 2024 | Aquabeam System |
| Glaxosmithkline, LLC. | $120.15 | 2022-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Medtronic, INC. | $113.62 | 2022 | |
| Intuitive Surgical, INC. | $112.15 | 2022 | |
| Pfizer INC. | $60.50 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $49.24 | 2023-2024 | Farxiga |
| Abbott Laboratories | $45.85 | 2023 | Freestyle Libre 2 |
| Biohaven Pharmaceutical Holding Company LTD. | $30.14 | 2022 | |
| Dynavax Technologies Corporation | $22.97 | 2024 | Heplisav-B |
| Merck Sharp & Dohme LLC | $22.05 | 2025 | Capvaxive, Gardasil 9 |
| Exact Sciences Corporation | $21.83 | 2023 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.21 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $13.29 | 2023 | Quviviq |
| Phadia US INC. | $12.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rina Bhalani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.